ACRES Commercial Realty Corp.
ACR NYSE Real Estate Investment Trusts Financials FY2016βFY2025
What ACRES Commercial Realty Corp. does
No business description yet.
- Legal name
- ACRES Commercial Realty Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 10, 2026
- Accession Β· CIK
- 0001193125-26-098916
0001332551
Revenue and margins
ACRES Commercial Realty Corp. had $79.9M of revenue in fiscal 2025, down 4.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ACRES Commercial Realty Corp. returned $22.3M to shareholders in fiscal 2025. The diluted share count fell 6.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably ACRES Commercial Realty Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $35.5M | $66.2M | $83.4M | $56.7M | $83.8M |
| Debt incl. finance leases | $1.8B | $1.9B | $1.7B | $1.4B | $1.6B |
| Debt / equity | 4.1x | 4.3x | 3.9x | 3.1x | 3.7x |
| Total assets | $2.3B | $2.4B | $2.2B | $1.9B | $2.2B |
| Total liabilities | $1.8B | $1.9B | $1.7B | $1.4B | $1.6B |
| Shareholders' equity | $448M | $435M | $436M | $439M | $421M |
| Net debt (β = net cash) | $1.8B | $1.8B | $1.6B | $1.3B | $1.5B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 7 | 5 / 7 | 4 / 7 | 3 / 7 | 5 / 7 | 6 / 7 | 7 / 7 | 6 / 7 | 4 / 7 |
| Accruals ratio | β0.6% | β9.5% | β1.0% | β0.3% | β11.2% | β0.3% | β1.0% | β1.0% | 0.5% | 1.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $62.7M | $43.7M | $55.3M | $61.2M | $50.3M | $50.1M | $75.2M | $91.1M | $83.5M | $79.9M |
| Net interest income | $58.9M | $41.7M | $55.2M | $61.0M | $50.2M | $39.5M | $44.0M | $56.7M | $41.2M | $33.2M |
| Provision for credit losses | $17.8M | $1.8M | β$1.6M | $0.1M | $30.8M | β$21.3M | $12.3M | $10.9M | $4.8M | β$7.7M |
| Interest expense | $53.7M | $57.7M | $67.6M | $83.8M | $58.0M | $61.6M | $82.3M | $131M | β | β |
| Pretax income | β | β | β | β | β | $33.9M | $10.8M | $21.9M | $28.8M | $27.9M |
| Income tax | $11.0M | $6.6M | β$0.3M | $0.0M | $0.0M | $0.0M | $0.3M | $0.1M | $0.1M | β$0.1M |
| Net income | β$30.6M | $33.3M | $27.4M | $36.0M | β$198M | $33.9M | $10.4M | $21.8M | $28.7M | $28.0M |
| Net income to common | β$53.0M | $5.7M | $7.0M | $25.6M | β$208M | $18.0M | β$8.8M | $3.0M | $9.1M | $0.2M |
| Diluted EPS | β$1.73 | $0.18 | $0.67 | $2.43 | β$19.33 | $1.85 | β$1.00 | $0.35 | $1.15 | $0.03 |
| Diluted shares | 0.03B | 0.03B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | β$18.9M | $222M | $48.2M | $43.3M | $31.8M | $40.6M | $32.7M | $45.6M | $19.4M | $4.1M |
| Capital expenditure | $0.0M | $0.0M | β | β | β | β | β | β | β | β |
| Free cash flow | β$18.9M | $222M | β | β | β | β | β | β | β | β |
| Depreciation and amortization | $1.6M | $0.1M | $0.1M | $0.0M | $0.0M | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M |
| Stock-based compensation | $3.0M | $2.7M | $2.7M | $2.2M | $3.1M | β | β | β | β | β |
| Acquisitions | $0.0M | $0.0M | $0.0M | β | β | β | β | β | β | β |
| Share buybacks | $9.5M | $0.0M | $0.0M | β | $5.4M | $18.4M | $9.1M | $7.4M | $7.9M | $22.3M |
| Dividends paid | $52.4M | $6.3M | $11.1M | $27.1M | $8.8M | β | β | β | β | β |
| Dividends and buybacks | $61.9M | $6.3M | $11.1M | $27.1M | $14.1M | $18.4M | $9.1M | $7.4M | $7.9M | $22.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $116M | $181M | $82.8M | $80.0M | $29.4M | $35.5M | $66.2M | $83.4M | $56.7M | $83.8M |
| Total debt | $1.2B | $1.2B | $1.6B | $1.9B | $1.3B | $1.8B | $1.9B | $1.7B | $1.4B | $1.6B |
| Loans, net | $19.3M | $75.9M | $0.0M | $19.5M | β | β | β | β | β | β |
| Intangible assets | $0.2M | $0.0M | β | β | $3.3M | $3.9M | $8.9M | $7.9M | $7.0M | $6.2M |
| Total assets | $2.1B | $1.9B | $2.1B | $2.5B | $1.7B | $2.3B | $2.4B | $2.2B | $1.9B | $2.2B |
| Total liabilities | $1.4B | $1.2B | $1.6B | $1.9B | $1.3B | $1.8B | $1.9B | $1.7B | $1.4B | $1.6B |
| Shareholders' equity | $704M | $671M | $554M | $556M | $334M | $448M | $435M | $436M | $439M | $421M |
| Margins | ||||||||||
| Net margin | β48.8% | 76.3% | 49.6% | 58.8% | β393.0% | 67.7% | 13.9% | 24.0% | 34.4% | 35.0% |
| FCF margin | β30.2% | 508.8% | β | β | β | β | β | β | β | β |
| Net interest share of revenue | 93.9% | 95.3% | 99.8% | 99.8% | 99.8% | 78.8% | 58.5% | 62.2% | 49.3% | 41.5% |
| Returns | ||||||||||
| Return on equity | β4.3% | 4.8% | 4.5% | 6.5% | β44.4% | 8.7% | 2.4% | 5.0% | 6.6% | 6.5% |
| Return on assets | β1.5% | 1.7% | 1.4% | 1.6% | β9.6% | 1.7% | 0.4% | 1.0% | 1.4% | 1.4% |
| Return on tangible equity | β7.5% | 0.8% | 1.3% | 4.6% | β62.8% | 4.1% | β2.1% | 0.7% | 2.1% | 0.1% |
| Growth | ||||||||||
| Revenue growth | β | β30.3% | 26.5% | 10.6% | β17.7% | β0.5% | 50.1% | 21.2% | β8.4% | β4.2% |
| Net income growth | β | β | β17.7% | 31.1% | β649.7% | β | β69.3% | 109.6% | 31.3% | β2.5% |
| EPS growth | β | β | 272.2% | 262.7% | β895.5% | β | β154.1% | β | 228.6% | β97.4% |
| Share count change | β | 1.8% | β66.3% | 0.9% | 2.0% | β9.3% | β9.7% | β2.8% | β7.5% | β6.5% |
| Financial health | ||||||||||
| Debt / equity | 1.7x | 1.7x | 2.9x | 3.4x | 4.0x | 4.1x | 4.3x | 3.9x | 3.1x | 3.7x |
| Provision / loans | 92.0% | 2.3% | β4,968.8% | 0.3% | β | β | β | β | β | β |
| Capital allocation | ||||||||||
| Capex / revenue | 0.0% | 0.0% | β | β | β | β | β | β | β | β |
| Stock comp / revenue | 4.8% | 6.3% | 4.9% | 3.6% | 6.2% | β | β | β | β | β |
| Payouts / FCF | β | 2.8% | β | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 5.0 | 4.0 | 3.0 | 5.0 | 6.0 | 7.0 | 6.0 | 4.0 |
| Accruals ratio | β0.6% | β9.5% | β1.0% | β0.3% | β11.2% | β0.3% | β1.0% | β1.0% | 0.5% | 1.2% |
Source: SEC EDGAR XBRL filings (CIK 0001332551). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.